Anti-inflammatory activity of citrus pectin on chicken monocytes' immune response.

Pectin is a dietary fibre composed of galacturonic acid, primarily found in the citrus fruits' cell walls. Citrus pectin (CP) has demonstrated antioxidative, anticancer, and anti-inflammatory properties in humans and animals. In broilers, CP supplementation improves energy utilization and nutrient digestibility, but limited information on its effects on chicken immunity is available so far. This study aimed to assess the in vitro impact of CP on chicken monocytes' immune response. Cells were purified from whole blood of healthy chickens and incubated with increasing concentrations (0, 0.25, 0.5, 0.75, 1 mg/mL) of CP to determine CP working concentration. The effects of different CP concentrations on cells' apoptosis and viability were assessed by measuring caspase-3 and -7 and the cells' metabolic activity (MTT assay), respectively. CP had no dose-dependent effect on monocyte apoptosis and viability.Then, the effects of CP (0.5 mg/mL) on chicken monocytes' chemotaxis and phagocytosis were assessed by measuring transwell migration and fluorescein-labelled E. coli incorporation, respectively. CP inhibited both monocytes' chemotaxis and phagocytosis.These data demonstrate that CP exerts an immunomodulatory role in chicken monocytes, supporting its integration in nutrition strategies that might be beneficial for the animal's immunity and health.

A genetic marker of hyperuricemia predicts cardiovascular events in a meta-analysis of three cohort studies in high risk patients.

INTRODUCTION: The strongest genetic marker of uric acid levels, the rs734553 SNP in the GLUT9 urate transporter gene, predicts progression to kidney failure in CKD patients and associates with systolic BP and carotid intima media thickness in family-based studies. METHODS: Since genes are transmitted randomly (Mendelian randomization) we used this gene polymorphism as an unconfounded research instrument to further explore the link between uric acid and cardiovascular disease (cardiovascular death, and non-fatal myocardial infarction and stroke) in a meta-analysis of three cohort studies formed by high risk patients (MAURO: 755 CKD patients; GHS: 353 type 2 diabetics and coronary artery disease and the TVAS: 119 patients with myocardial infarction). RESULTS: In separate analyses of the three cohorts, the incidence rate of CV events was higher in patients with the rs734553 risk (T) allele (TT/GT) than in those without (GG patients) and the HR in TT/GT patients in the three cohorts (range 1.72-2.14) coherently signaled an excessive cardiovascular risk with no heterogeneity (I2 = 0.01). The meta-analytical estimate (total number of patients, n = 1227; total CV events, n = 222) of the HR for the combined end-point in TT/GT patients was twice higher (pooled HR: 2.04, 95% CI: 1.11-3.75, P = 0.02) than in GG homozygotes. CONCLUSIONS: The T allele of the rs734553 polymorphism in the GLUT9 gene predicts a doubling in the risk for incident cardiovascular events in patients at high cardiovascular risk. Findings in this study are compatible with the hypothesis of a causal role of hyperuricemia in cardiovascular disease in high risk conditions.

Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression.

BACKGROUND & AIMS: We have recently reported that a polymorphism (rs734553) in a major urate transporter gene (GLUT9) is a strong predictor of incident renal events in stage 2-5 CKD patients implying that life-time exposure to high uric acid levels may be causally implicated in CKD progression. Since disturbed NO bioavailability is a major pathway whereby high uric may cause renal damage, we tested the interaction between the major endogenous inhibitor of NO synthase, asymmetric-dimethylargine (ADMA), and the rs734553 polymorphism for CKD progression in the same cohort. METHODS & RESULTS: Over a 29 ± 11 months follow-up the risk for incident renal events was higher in patients harboring the risk allele of the polymorphism (T) as compared to those without the risk allele (HR: 2.35, 95% CI: 1.25-4.42, P = 0.008) (p = 0.01). Similarly, patients with ADMA > median value had an increased risk for the same outcome (HR: 1.37, 95% CI: 1.06-1.76, P = 0.016). Interaction analysis showed a strong amplification by ADMA of the risk for renal events associated to the T allele because in adjusted (P = 0.016) and bootstrapping validated (P = 0.020) analyses the risk excess associated to this allele was progressively higher across increasing ADMA levels. CONCLUSIONS: The rs734553 polymorphism, the strongest genetic marker of uric acid levels discovered so far, interacts with ADMA in determining the risk for CKD progression in CKD patients. This synergic interaction conforms to biological knowledge indicating that disturbed NO bio-availability is a critical pathway whereby life time exposure to high uric acid may engender renal damage.

Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD).

BACKGROUND AND AIM: A decoy receptor for advanced glycation end product (soluble RAGE or sRAGE) is involved in left ventricular hypertrophy (LVH), and cardiomyopathy myocardial damage in experimental models and observational studies in patients with heart failure support the hypothesis that sRAGE attenuates the progression of heart disease and prevents death. Since sRAGE accumulates in patients with chronic kidney disease (CKD) we studied the relationship between plasma sRAGE with LVH in CKD patients. METHODS AND RESULTS: We enrolled 142 patients with an average estimated glomerular filtration rate (eGFR) of 32 ml/min/1.73 m(2) and 49 healthy control individuals matched for age and gender. Plasma sRAGE was significantly higher in CKD patients than in healthy controls. Significant inverse relationships were found between sRAGE with left ventricular mass index (LVMI) and mean wall thickness (MWT) but no such associations were found in controls. A bootstrap re-sampling validation study confirmed the estimates of the link between sRAGE and these variables. On covariance analysis, the slopes of LVMI and MWT to sRAGE were significantly steeper in CKD patients than in the controls. On logistic regression analysis 1 log unit increase in sRAGE was associated with a 82% decrease in the odds for LVH in CKD patients. CONCLUSIONS: sRAGE is an inverse marker of LVH in CKD patients. This association generates the hypothesis that the RAGE pathway could be a causal risk factor for LVH in this population and that blockade of this pathway by the endogenous decoy receptor sRAGE could attenuate LVH in the same population.

Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients.

BACKGROUND AND AIM: Systemic inflammation is a hallmark of chronic kidney disease (CKD) and obesity represents a major risk factor for CKD. We investigated the relationship between plasma interleukin-6 (IL-6) and tumour necrosis factor-α (TNF-α) and the glomerular filtration rate (GFR) in 75 stage 2-5 CKD patients. METHODS AND RESULTS: We studied the steady-state relationship between plasma and subcutaneous adipose tissue (SAT) gene expression of the same cytokines in 19 patients and in 17 well-matched healthy subjects (HS) and compared SAT gene expression of these cytokines and of two additional cytokines (IL-1ß and IL-8) in CKD patients and in HS. Plasma IL-6 and TNF-α were higher in CKD patients than in HS (P < 0.001). IL-6 was similarly increased in patients with mild, moderate and severe CKD and largely independent of the GFR (r = -0.03, P = NS). TNF-α was inversely related to GFR, which was the first factor in rank (ß = -0.37, P = 0.001) explaining the variability in TNF-α in CKD. SAT messenger RNA (mRNA) levels of IL-6, TNF-α, IL- ß and IL-8 were similar in CKD patients and in HS. Plasma and SAT mRNA levels of IL-6 and TNF-α levels were largely unrelated. CONCLUSIONS: Plasma IL-6 rises early in CKD and does not show any further increase at more severe stages of CKD, whereas TNF-α is inversely associated with the GFR indicating a substantial difference in the dynamics of the relationship between these cytokines and renal function. Cytokines are not overexpressed in SAT in these patients, and circulating IL-6 and TNF-α are dissociated from the corresponding mRNA levels in SAT, both in CKD patients and in HS.

Sleep disordered breathing in renal transplant patients.

Sleep disordered breathing (SDB) is a prevalent, important nontraditional cardiovascular (CV) risk factor in end-stage renal disease patients. The prevalence of SDB in renal transplant patients is unknown. We compared polysomnographic studies in 163 transplant patients with matched samples in the general population and explored longitudinally the effect of return to dialysis after graft failure on SDB in three consecutive cases. Episodes of nocturnal hypoxemia, average and minimal O(2) saturation overnight in transplant patients did not differ from those in individuals in the general population matched for age, gender and body mass index (BMI). The prevalence of moderate-to-severe SBD in these patients did not exceed the estimated prevalence of the same disturbance in the general population. The respiratory disturbance index in transplant patients was directly associated with BMI (p < 0.001). In the longitudinal study all indicators of SDB coherently increased after transplant failure. The prevalence of SDB in transplant patients does not differ from that in well-matched individuals in the general population. The favorable effect of renal transplantation on CV risk may be at least partially explained by the lack of risk excess for SDB in this population. Longitudinal observations after transplant failure are compatible with the hypothesis that renal transplantation reverses SDB.

Circulating E-selectin as a risk marker in patients with end-stage renal disease.

BACKGROUND: E-selectin is a key adhesion molecule which plays a fundamental role in endothelial progenitor cell-dependent reparative mechanisms in experimental ischaemia and it serves to anchor leucocytes to the endothelium in inflammatory processes. Inflammation is one of the strongest risk factors for death and cardiovascular (CV) events in end-stage renal disease (ESRD). OBJECTIVE: The objective of the current study was to evaluate whether E-selectin is a useful biomarker of clinical outcome in ESRD patients. We tested the prediction power of circulating E-selectin for mortality and CV events in a cohort of 265 ESRD patients. RESULTS: During the follow-up, 59 patients died and 58 had CV events. All-cause mortality was inversely related to serum E-selectin, the risk of death being the lowest in patients in the third E-selectin tertile (HR: 1, reference group), intermediate in those in the second tertile (HR: 1.30) and the highest in patients in the first tertile (HR: 2.02, P = 0.01). Similarly, the risk of fatal and nonfatal CV events followed an inverse pattern being lowest in the third tertile (reference group) and highest in the first tertile (HR: 1.73, P = 0.03). The prediction power of E-selectin for death and CV events was confirmed in a Cox regression analysis where E-selectin emerged as an inverse predictor of these outcomes, particularly so in patients with severe inflammation. CONCLUSIONS: These data are in keeping with the hypothesis that in systemic inflammation altered E-selectin shedding may play a role in arterial damage and implicates this adhesion molecule in atherosclerotic complications in a high-risk condition like ESRD.

Relationship of parent driving records to the driving records of their children.

Many studies have shown that young driver crash rates can be influenced by such factors as lifestyle characteristics and licensing systems. However, the influence of parents on their teenage children's crash and violation rates has not received much attention. The present study used data from the North Carolina driver history file to match the crash and violation records of young drivers between the ages of 18 and 21 with those of their parents. Results indicate that children's driving records in the first few years of licensure are related to the driving records of their parents. Children whose parents had three or more crashes on their record were 22% more likely to have had at least one crash compared with children whose parents had no crashes. Likewise, children whose parents had three or more violations were 38% more likely to have had a violation compared with children whose parents had none. Logistic regression models showed that these relationships held when controlling for household type and child gender.

The use of calcium sulphate in the surgical treatment of a 'through and through' periradicular lesion.

AIM: This randomized, controlled, clinical study was designed to evaluate the adjunctive effect of calcium sulphate grafts on the surgical treatment of through and through periradicular lesions. METHODOLOGY: Twenty patients each with one tooth showing evidence radiologically of a periradicular lesion wider than 10 mm, with lack of both buccal and lingual cortical bony plates and an indication for surgery were selected for the study. Ten teeth were treated with apicectomy, root-end filling and grafting of the bone defect with calcium sulphate prior to suturing (test group). The other 10 teeth received the same surgical therapy but no grafting with calcium sulphate (control group). The outcome of the healing process was evaluated at 6 and 12 months radiographically following the criteria reported by Rud and Andreasen. RESULTS: At the six- and 12-month evaluation the test group had seven teeth with complete healing and two with incomplete healing, whilst the control group showed three teeth with complete healing, five with incomplete healing and one with unsatisfactory healing. One tooth in each group had to be extracted because of a vertical fracture that occurred during the follow-up period. CONCLUSIONS: The results of the study demonstrate that the addition of calcium sulphate as a bone graft during the conventional surgical treatment of through and through lesions improves the clinical outcome. Histological analysis is desirable to investigate the quality of tissues formed using the two surgical procedures.

Prospective study on the augmentation of the maxillary sinus with calcium sulfate: histological results.

BACKGROUND: The main goal of the sinus elevation procedure is the formation of vital bone to allow the tissue integration of endosseous implants to support prosthetic restorations in the edentulous posterior maxilla. The ideal graft material is yet to be found. The present study investigated the histologic results of a sinus augmentation procedure performed with calcium sulfate as the grafting material. METHODS: The clinical trial consisted of 2 groups: a first (control) group of 12 patients (15 sinuses) in which the material was carefully placed but not stratified. In the second (test) group, 45 patients (50 sinuses) were treated by modifying the application. The calcium sulfate was putty-like in consistency and placed as it hardened in layers, avoiding fluid contamination. The histologic samples were collected, either at 9 months, at the uncovering procedure (for implants placed simultaneously with grafting material), or at 6 months at the time of implant insertion (for implants placed at a later stage). RESULTS: The augmentation procedure resulted in good, new tissue formation within the sinuses when clinically and radiographically evaluated. The technique used in the test group produced a reduction in the graft shrinkage during healing, therefore slowing down the material resorption rate. Histologically, new bone formation with progressive lamellar maturation was found in both groups. Some particles produced by calcium sulfate resorption were still present after 6 months in the test group specimens, but no longer detectable after 9 months. Samples from the control group showed a mean histomorphometric bone density of 34.25% +/- 10.02, while samples from the test group showed a mean value of 55.54% +/- 19.82. CONCLUSIONS: The results of this study indicate that calcium sulfate appears to be an effective material for sinus augmentation, yielding vital bone suitable for implant integration. In addition, the technique used in the test group seemed to improve the quality and quantity of bone formation.

Augmentation of the maxillary sinus with calcium sulfate: one-year clinical report from a prospective longitudinal study.

The aim of the present investigation was to evaluate the clinical and histologic results of a sinus augmentation procedure performed using calcium sulfate as the grafting material. A group of 12 patients (15 sinuses) formed the pilot group. Based on the experience of the pilot group, the technique of calcium sulfate application was modified, and a second group of 45 patients (50 sinuses) was subsequently treated (test group). In the pilot group, a total of 30 implants (Biolock) was placed. In the test group, a total of 100 implants (Biolock and Biohorizons) was placed. The clinical data reported in the present study are related to the 1-year follow-up for both groups. Clinical evaluations, including assessment of implant mobility and probing pocket depth, were recorded on a monthly basis following implant uncovering until final prosthesis placement, and every 6 months thereafter. Radiographs were taken prior to sinus augmentation, monthly until 6 months postoperatively, 9 and 12 months after implantation, and at yearly intervals thereafter. One implant in the pilot group was not integrated at second-stage surgery, and 1 in the test group failed to maintain osseointegration after the abutment connection (at the 1-year evaluation). Based on defined criteria, the overall success rate for the 130 placed implants 1 year postimplantation was 98.5%. Clinical and radiographic evaluation revealed that the augmentation procedure resulted in new tissue formation within the sinuses. The technique used in the test group suggested a slowdown in material resorption and a reduction in graft shrinkage during healing. Bone biopsies were harvested for histologic evaluation. The application of a resorbable barrier membrane to the access window reduced the invagination of soft tissue at that level. The results of this study support the hypothesis that calcium sulfate may be a suitable material for sinus augmentation.

Osseointegration of rough acid-etched titanium implants: 5-year follow-up of 100 minimatic implants.

During 1992, 100 Minimatic screw implants made of titanium alloy (titanium-aluminum-vanadium) with a machined rough acid-etched surface were placed in 63 consecutive partially edentulous patients. At second-stage surgery, which was performed after a 4- to 6-month healing period, none of the implants showed signs of mobility, peri-implant infection, or bone loss from the crest of the ridge. Each patient was restored with a fixed prosthesis and reexamined every 3 months during the first year. Periapical radiographs were taken annually up to 5 years. These revealed no signs of peri-implant radiolucencies involving any of the implants, and mean alveolar bone loss was less than 1 mm at the 5-year examination. One implant was considered a late failure because of a peri-implant infection that developed during the first year, although the implant was still functional at year 5. Another patient with 2 implants dropped out during the fifth year of the study, although both implants had been considered successful up to that point. Based on annual measurements of Plaque Index, Sulcular Bleeding index, pocket probing depth, attachment level, width of keratinized mucosa, and hand-tested mobility, 97 of the remaining 98 implants were considered successful, resulting in a 98% success rate. This 5-year study confirms that Minimatic machined acid-etched implants provide predictable osseointegration results and supports the conclusion of other reports that titanium implants with a rough surface can fulfill the requirements of Albrektsson et al (1986) for implant success.

Source memory and eyewitness suggestibility in older adults.

The authors investigated the influence of test format on the source-memory performance of older adults (N = 128). Each participant viewed a picture and wrote a description of the scene. Then half of the participants (control group) read a text that accurately described the scene; the other half (misled group) read a text that contained misinformation. After writing another scene description, the participants were given a surprise memory test. Half were given a yes/no recognition test, and half were given a source-monitoring test. The misled yes/no participants mistakenly indicated more often than the control yes/no participants that misleading-text items were in the picture (suggestibility effect). There was no suggestibility effect for source-monitoring participants. The data are discussed in terms of the source monitoring framework.

Clinical evaluation of the treatment of class II furcation involvements with bioabsorbable barriers alone or associated with demineralized freeze-dried bone allografts.

BACKGROUND: Class II furcation lesions are a challenging scenario for periodontal therapy and a serious threat for tooth prognosis. Guided tissue regeneration represents a viable treatment option, but some aspects remain to be clarified as to the efficacy of bone substitutes used in GTR procedures. The clinical efficacy of demineralized freeze-dried bone allografts (DFDBA) for regenerative procedures is presently under scrutiny. METHODS: This study evaluated the adjunctive clinical effects of DFDBA associated with a bioabsorbable (polylactic acid) barrier membrane in the regenerative treatment of human Class II furcation lesions as compared to the same type of barrier alone. Twelve patients with bilateral Class II furcation defects on lower first molars participated in the study. In each patient, one tooth was randomly assigned to treatment consisting of open surgical debridement followed by the placement of DFDBA (GTR+DFDBA, or test group) and a bioabsorbable barrier, while the contralateral side received the same flap surgery followed by use of the bioabsorbable membrane alone (GTR, or control group). The clinical efficacy of the 2 treatment modalities was evaluated at 6 and 12 months postoperatively. Measurements included vertical probing depth (VPD), horizontal probing depth (HPD), clinical attachment level (CAL), amount of gingival recession (GR), and change in class of clinically detectable furcation involvement (FC). RESULTS: Both treatments yielded significant improvements for all clinical parameters between baseline and 6 and 12 months (P<0.05). The comparison between test and control groups revealed significantly greater reduction in HPD (P=0.01) and higher values of GR (P=0.008) for the test group. The mean gain in HPD for test sites was 2.3 mm, while it amounted to 1.7 mm for controls. A significantly greater proportion of test sites could be classified postoperatively as Class I defects compared to controls (91% versus 50%, respectively). CONCLUSIONS: The results of this study indicate that significant improvements from baseline occurred in VPD, HPD, CAL, and clinically detectable furcation involvement after the treatment of Class II furcation lesions with a bioabsorbable membrane with or without the adjunctive use of DFDBA. In addition, the placement of DFDBA in the furcation defect under the bioabsorbable membrane resulted in a greater mean reduction of horizontal probing depth when compared to the regenerative therapy alone.

Short-term healing following the use of calcium sulfate as a grafting material for sinus augmentation: a clinical report.

Because of the frequent lack of bone in the posterior maxilla, sinus augmentation has become a commonly practiced treatment modality. Many different materials have been used for augmenting the sinus, and the ideal graft is yet to be found. The present article reports the results of sinuses grafted with calcium sulfate in 2 patients. Bone biopsies were harvested 9 months after the augmentation procedure. In the first patient, 3 titanium threaded-cylinder implants were placed in the grafted area after 9 months, while in the second, 1 acid-etched, screw-shaped titanium implant was placed simultaneously with the graft. Light microscopic evaluation revealed new bone formation with ongoing remodeling and progressive lamellar maturation in the specimens. No remnants of the alloplastic material were detectable in any section, either within the bone or in the medullary tissue. When reevaluated at the uncovering procedure, the implants were radiographically and clinically judged to be osseointegrated. These observations suggest that, when used in the appropriate form and with the proper technique, calcium sulfate is a promising graft material for sinus augmentation, producing adequate quantity and quality of new bone for implant placement.

Aging and source monitoring: cognitive processes and neuropsychological correlates.

This study shows that relative to younger adults, older adults are more adversely influenced by similar items when judging a memory's source, and the phenomenal features of their correctly and incorrectly attributed memories have greater overlap. The authors argue in accordance with the source monitoring framework that this age-related impairment in source accuracy is related to processes involved in binding features into complex memories and those involved in accessing and evaluating contextual features of memories. These processes are linked to medial temporal and frontal brain regions, respectively, as evidenced by correlations in older adults between source accuracy and neuropsychological tests often used to assess medial temporal and frontal function. The results suggest that adequate feature binding is particularly important when items from different source share similar features and access-evaluation processes are particularly important after a delay.

Osseointegration of rough acid-etched implants: one-year follow-up of placement of 100 minimatic implants.

Between January 1992 and October 1992, 100 Minimatic screw implants made of titanium alloy with rough acid-etched surfaces were placed in 63 consecutive partially edentulous patients. At second-stage (uncovering) surgery performed after a 4- to 6-month healing period, none of the implants showed any signs of mobility, peri-implant infection, or bone loss. After an additional healing phase averaging 2 weeks, the patients were restored with fixed prostheses. Patients were reexamined every 3 months for 1 year, with all 63 patients available for evaluation during this period. Periapical radiographs were taken preoperatively, immediately after surgery, and at 6 and 12 months after implantation. There were no signs of peri-implant radiolucencies in any of the implants, and alveolar bone loss was less than 1 mm on average 1 year after implantation. Based on Plaque Index, sulcular bleeding index, pocket probing depth, attachment level, width of keratinized mucosa, and hand-tested mobility, 99 implants were considered successful and 1 (which developed peri-implant infection) was considered a failure. Study results substantiate other reports that implants with a rough surface can yield predictable good results.

Reproducibility of the response to short-term low salt intake in essential hypertension.

BACKGROUND: The reproducibility of the arterial pressure response to change in salt intake in essential hypertensives has been little investigated. OBJECTIVE: To study the reproducibility of the response to salt in 14 untreated patients with mild essential hypertension. METHODS: After a run-in phase (1 month), each patient ingested, in random order and with cross-over, 1 week of high salt intake (170 mmol/day) and 1 week of low salt intake (40 mmol/day). The identical experimental protocol was then repeated after an average interval of 3.4 months. Arterial pressure was measured (clinic arterial pressure and 24 h ambulatory monitoring) on the seventh day of each diet period. The reproducibility of the arterial pressure response was assessed in terms the intraclass correlation coefficient and the K statistics. RESULTS: There was a good compliance with the dietary prescription because the urinary Na excretion was on average very close to the prescribed intake both during the first and during the second salt intake period. Both clinic and 24 h arterial pressure fell significantly (P < 0.01) and to the same extent in the low-salt phases of the study. Clinic arterial pressure was consistently higher than 24 h ambulatory arterial pressure but the average changes induced by salt depletion were similar. The variability of 24 h ambulatory arterial pressure at constant salt intake was lower than that of clinic arterial pressure. However, the arterial pressure response to salt showed the same variability with the two methods. The reproducibility of the dichotomous classification of patients into salt-sensitive and -resistant was low both in terms of 24 h ambulatory and in terms of clinic blood pressure. CONCLUSION: Although on rechallenging the average arterial pressure response to salt remains unchanged in essential hypertensives, the individual responses are variable and the reproducibility of the dichotomous classification is unsatisfactory. The problem of dichotomizing patients into salt-sensitive and -resistant ones is only in very little part resolved by more precise arterial pressure estimates.

Does high salt intake cause hyperfiltration in patients with essential hypertension?

In animal models of salt-dependent hypertension, hyperfiltration is associated with a faster decline in renal function and there is evidence that in hypertensive man, increased creatinine clearance is a marker of early hypertensive nephropathy. We have studied the influence of salt intake on the glomerular filtration rate (GFR) (Creatinine Clearance) in 14 patients with mild hypertension. Each patient was studied in random order and according to a crossover design, at habitual salt intake, at high salt intake (ie habitual +50/100 mmol/day) and at low salt intake (habitual -50/100 mmol/day). Protein, calcium and potassium intake was fixed across the three study periods. The control group was formed by seven healthy subjects. High salt intake, caused a significant (P < 0.01) increase in 24 h mean arterial pressure (MAP) and the expected suppression in plasma renin activity (PRA) and in plasma aldosterone. Seven patients were classified as salt-sensitive. The GFR was significantly higher (P < 0.01) at high salt intake (125 +/- 10 ml/min) than at habitual (113 +/- 7 ml/min) and at low salt intake (97 +/- 6 ml/min). On aggregate urinary salt excretion was significantly related with the GFR (P < 0.01 by correlation analysis for repeated observations) and the slope of this relationship predicted that a 100 mmol/day increase in salt intake is associated with the 14.6 ml/min rise in the GFR. The relationship between GFR and 24 h urinary salt in salt sensitive patients did not differ from that in salt resistant patients. The GFR response to salt loading was largely independent of the renin-aldosterone system. No change in arterial pressure nor in GFR was observed in healthy subjects. At fixed protein intake, changes in salt intake in the physiological range are associated with important GFR variations in mild hypertensives. As long as hyperfiltration in mild hypertension is a predictor of renal function deterioration, high salt intake, independent of the effect of arterial pressure, could be a factor that contributes to nephronic obsolescence in patients with essential hypertension.